Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17.
Girón-Callejas A, García-Morales C, Mendizabal-Burastero R, Meza RI, Sierra T, Tapia-Trejo D, Pérez-García M, Quiroz-Morales VS, Paredes M, Rodríguez A, Juárez SI, Farach N, Videa G, Lara B, Rodríguez E, Ardón E, Sajquim E, Lorenzana R, Ravasi G, Northbrook S, Reyes-Terán G, Ávila-Ríos S. Girón-Callejas A, et al. Among authors: quiroz morales vs. J Antimicrob Chemother. 2020 Jul 1;75(7):1932-1942. doi: 10.1093/jac/dkaa100. J Antimicrob Chemother. 2020. PMID: 32303063
HIV pretreatment drug resistance trends in three geographic areas of Mexico.
García-Morales C, Tapia-Trejo D, Quiroz-Morales VS, Navarro-Álvarez S, Barrera-Arellano CA, Casillas-Rodríguez J, Romero-Mora KA, Gómez-Palacio-Schjetnan M, Murakami-Ogasawara A, Ávila-Ríos S, Reyes-Terán G; HIVDR MexNet Group. García-Morales C, et al. Among authors: quiroz morales vs. J Antimicrob Chemother. 2017 Nov 1;72(11):3149-3158. doi: 10.1093/jac/dkx281. J Antimicrob Chemother. 2017. PMID: 28961972
HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: a sub-nationally representative survey.
Ávila-Ríos S, García-Morales C, Valenzuela-Lara M, Chaillon A, Tapia-Trejo D, Pérez-García M, López-Sánchez DM, Maza-Sánchez L, Del Arenal-Sánchez SJ, Paz-Juárez HE, Quiroz-Morales VS, Mehta SR, Smith DM, León-Juárez EA, Magis-Rodríguez C, Reyes-Terán G; HIVDR MexNet Group. Ávila-Ríos S, et al. Among authors: quiroz morales vs. J Antimicrob Chemother. 2019 Apr 1;74(4):1044-1055. doi: 10.1093/jac/dky512. J Antimicrob Chemother. 2019. PMID: 30597094 Free PMC article.
High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
Girón-Callejas A, García-Morales C, Mendizabal-Burastero R, Román M, Tapia-Trejo D, Pérez-García M, Quiroz-Morales VS, Juárez SI, Ravasi G, Vargas C, Gutiérrez R, Romero L, Solórzano A, Sajquim E, Northbrook S, Ávila-Ríos S, Reyes-Terán G. Girón-Callejas A, et al. Among authors: quiroz morales vs. J Int AIDS Soc. 2019 Dec;22(12):e25429. doi: 10.1002/jia2.25429. J Int AIDS Soc. 2019. PMID: 31860167 Free PMC article.
Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
Ávila-Ríos S, García-Morales C, Matías-Florentino M, Romero-Mora KA, Tapia-Trejo D, Quiroz-Morales VS, Reyes-Gopar H, Ji H, Sandstrom P, Casillas-Rodríguez J, Sierra-Madero J, León-Juárez EA, Valenzuela-Lara M, Magis-Rodríguez C, Uribe-Zuñiga P, Reyes-Terán G; HIVDR MexNet Group. Ávila-Ríos S, et al. Among authors: quiroz morales vs. Lancet HIV. 2016 Dec;3(12):e579-e591. doi: 10.1016/S2352-3018(16)30119-9. Epub 2016 Sep 14. Lancet HIV. 2016. PMID: 27658867
HIV Pretreatment Drug Resistance Trends in Mexico City, 2017-2020.
García-Morales C, Tapia-Trejo D, Matías-Florentino M, Quiroz-Morales VS, Dávila-Conn V, Beristain-Barreda Á, Cárdenas-Sandoval M, Becerril-Rodríguez M, Iracheta-Hernández P, Macías-González I, García-Mendiola R, Guzmán-Carmona A, Zarza-Sánchez E, Cruz RA, González-Rodríguez A, Reyes-Terán G, Ávila-Ríos S. García-Morales C, et al. Among authors: quiroz morales vs. Pathogens. 2021 Dec 8;10(12):1587. doi: 10.3390/pathogens10121587. Pathogens. 2021. PMID: 34959542 Free PMC article.
Novel HLA class I associations with HIV-1 control in a unique genetically admixed population.
Valenzuela-Ponce H, Alva-Hernández S, Garrido-Rodríguez D, Soto-Nava M, García-Téllez T, Escamilla-Gómez T, García-Morales C, Quiroz-Morales VS, Tapia-Trejo D, Del Arenal-Sánchez S, Prado-Galbarro FJ, Hernández-Juan R, Rodríguez-Aguirre E, Murakami-Ogasawara A, Mejía-Villatoro C, Escobar-Urias IY, Pinzón-Meza R, Pascale JM, Zaldivar Y, Porras-Cortés G, Quant-Durán C, Lorenzana I, Meza RI, Palou EY, Manzanero M, Cedillos RA, Aláez C, Brockman MA, Harrigan PR, Brumme CJ, Brumme ZL, Ávila-Ríos S, Reyes-Terán G; Mesoamerican HIV Project Group. Valenzuela-Ponce H, et al. Among authors: quiroz morales vs. Sci Rep. 2018 Apr 17;8(1):6111. doi: 10.1038/s41598-018-23849-7. Sci Rep. 2018. PMID: 29666450 Free PMC article.